We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fluorophotometry Evaluation of Lubricant Eye Drops

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00347854
First Posted: July 4, 2006
Last Update Posted: November 22, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Alcon Research
June 30, 2006
July 4, 2006
November 22, 2016
April 2006
April 2006   (Final data collection date for primary outcome measure)
Epithelial permeability to fluorescein
Same as current
Complete list of historical versions of study NCT00347854 on ClinicalTrials.gov Archive Site
tear turnover rate
Same as current
Not Provided
Not Provided
 
Fluorophotometry Evaluation of Lubricant Eye Drops
Fluorophotometry Evaluation of Lubricant Eye Drops FID 105783
The objective of this study is to evaluate the safety and efficacy of exaggerated use of Lubricant Eye Drops in a population of normal subjects by measuring corneal epithelial permeability to fluorescein.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Healthy
  • Other: Systane Free lubricant eye drops
  • Other: Visine Tears Lubricant Eye Drops
  • Other: Refresh Liquigel Lubricant Eye Drops
  • Other: Refresh Plus Lubricant Eye Drops
  • Experimental: FID 105783
    Intervention: Other: Systane Free lubricant eye drops
  • Active Comparator: Visine
    Intervention: Other: Visine Tears Lubricant Eye Drops
  • Active Comparator: Refresh Liquigel
    Intervention: Other: Refresh Liquigel Lubricant Eye Drops
  • Active Comparator: Refresh Plus
    Intervention: Other: Refresh Plus Lubricant Eye Drops
http://www.aaopt.org/evaluation-new-preservation-system-corneal-barrier-function

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
April 2006
April 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Ages 18 and over

Exclusion Criteria:

  • No sodium fluorescein corneal staining at Screening Visit
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00347854
C-05-06
No
Not Provided
Not Provided
Alcon Research
Alcon Research
Not Provided
Study Director: Mike Christensen Alcon Research
Alcon Research
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP
To Top